NEWS
A new study has found that vitamin E deficiency is associated with an increased risk of contracting tuberculosis (TB).
COMMENT
World Health Organization statistics show that in 2016 10.4 million people fell ill with TB, and 1.7 million died from the disease. However, because TB bacteria have now developed resistance to almost all available standard treatment options, this death rate is expected to increase. As such, new approaches to treating TB are desperately needed.
Significantly, therefore, researchers at the Dr. Rath Research Institute have conducted a clinical trial in 120 hospitalized patients with active pulmonary TB to investigate how a combination of specific micronutrients, when taken along with standard treatments, affects the healing process. At the end of the study, as evidenced by their chest X-rays and other measured parameters, the patients taking the micronutrients had significantly greater signs of healing. In particular, their cavity healing was almost 30 percent higher than that of the control group of patients who received only standard TB treatment. Moreover, all (i.e. 100 percent) of the patients in the group taking the micronutrients tested negative to the TB bacteria. In contrast, only 88 percent of the patients in the control group had a negative TB test.
To learn more about the clinical benefits of micronutrients in tuberculosis, read this article from the Research News Pages section of our website.
Read article at medicalnewsbulletin.com
Patients not being told about doctors’ pharma conflicts of interest
April 3, 2018Future phone apps may monitor whether patients take their prescribed drugs
April 4, 2018Vitamin E deficiency associated with increased risk of tuberculosis
NEWS
A new study has found that vitamin E deficiency is associated with an increased risk of contracting tuberculosis (TB).
COMMENT
World Health Organization statistics show that in 2016 10.4 million people fell ill with TB, and 1.7 million died from the disease. However, because TB bacteria have now developed resistance to almost all available standard treatment options, this death rate is expected to increase. As such, new approaches to treating TB are desperately needed.
Significantly, therefore, researchers at the Dr. Rath Research Institute have conducted a clinical trial in 120 hospitalized patients with active pulmonary TB to investigate how a combination of specific micronutrients, when taken along with standard treatments, affects the healing process. At the end of the study, as evidenced by their chest X-rays and other measured parameters, the patients taking the micronutrients had significantly greater signs of healing. In particular, their cavity healing was almost 30 percent higher than that of the control group of patients who received only standard TB treatment. Moreover, all (i.e. 100 percent) of the patients in the group taking the micronutrients tested negative to the TB bacteria. In contrast, only 88 percent of the patients in the control group had a negative TB test.
To learn more about the clinical benefits of micronutrients in tuberculosis, read this article from the Research News Pages section of our website.
Read article at medicalnewsbulletin.comDr. Rath Health Foundation
Related posts
Efficacy of Mpox Vaccine Wanes Within a Year, Studies Reveal
Read more